Theravance, Inc. (JOBS) Says FDA Asks for More Data on Telavancin

Feb 26 (Reuters) - Theravance Inc said the U.S. health regulators asked for more study data, label revisions and safety update on its experimental antibiotic for serious skin infections, sending its shares down about 9 percent after the bell.